Edition:
United States

Minapharm Pharmaceuticals SAE (MIPH.CA)

MIPH.CA on Cairo Stock Exchange

61.00EGP
19 Sep 2017
Change (% chg)

£2.56 (+4.38%)
Prev Close
£58.44
Open
£61.00
Day's High
£61.00
Day's Low
£61.00
Volume
472
Avg. Vol
355
52-wk High
£77.41
52-wk Low
£45.00

Chart for

About

Minapharm Pharmaceuticals SAE is an Egypt-based company engaged in the production and distribution of pharmaceutical products. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.61
Market Cap(Mil.): £718.43
Shares Outstanding(Mil.): 12.29
Dividend: 4.50
Yield (%): 6.93

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.18
EPS (TTM): -- -- --
ROI: -- 15.15 14.60
ROE: -- 16.38 13.87

BRIEF-Minapharm Pharmaceuticals Q1 profit falls

* Q1 net profit EGP 7.7 million versus EGP 29.1 million year ago

May 15 2017

Earnings vs. Estimates

No consensus analysis data available.